Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

The role of melanocortin peptides and receptors in regulation of energy balance.

Zimanyi IA, Pelleymounter MA.

Curr Pharm Des. 2003;9(8):627-41. Review.

PMID:
12570796
2.

Central control of feeding behavior by neuropeptide Y.

Zimanyi IA, Fathi Z, Poindexter GS.

Curr Pharm Des. 1998 Aug;4(4):349-66. Review.

PMID:
10197048
3.

Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.

Fathi Z, Battaglino PM, Iben LG, Li H, Baker E, Zhang D, McGovern R, Mahle CD, Sutherland GR, Iismaa TP, Dickinson KE, Zimanyi IA.

Brain Res Mol Brain Res. 1998 Jul 15;58(1-2):156-69.

PMID:
9685625
4.

Cloning, pharmacological characterization and distribution of a novel galanin receptor .

Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA, Pine KA, Wang J, Goldstein ME, Iismaa TP, Zimanyi IA.

Brain Res Mol Brain Res. 1998 Jan;53(1-2):348. No abstract available.

PMID:
9473722
5.

Cloning, pharmacological characterization and distribution of a novel galanin receptor.

Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA, Pine KA, Wang J, Goldstein ME, Iismaa TP, Zimanyi IA.

Brain Res Mol Brain Res. 1997 Nov;51(1-2):49-59. Erratum in: Brain Res Mol Brain Res 1998 Jan;53(1-2):348.

PMID:
9427506
6.
7.

Ryanodine induces persistent inactivation of the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum.

Zimányi I, Buck E, Abramson JJ, Mack MM, Pessah IN.

Mol Pharmacol. 1992 Dec;42(6):1049-57.

PMID:
1480132
8.

Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel.

Buck E, Zimanyi I, Abramson JJ, Pessah IN.

J Biol Chem. 1992 Nov 25;267(33):23560-7.

9.
10.
11.
13.
14.
15.

Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum.

Zimányi I, Lajtha A, Reith ME.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):626-32.

PMID:
2615854
16.

Evidence for a common site of action of lidocaine and carbamazepine in voltage-dependent sodium channels.

Zimányi I, Weiss SR, Lajtha A, Post RM, Reith ME.

Eur J Pharmacol. 1989 Aug 29;167(3):419-22.

PMID:
2553444
17.

Role of ions and membrane potential in uptake of serotonin into plasma membrane vesicles from mouse brain.

Reith ME, Zimanyi I, O'Reilly CA.

Biochem Pharmacol. 1989 Jul 1;38(13):2091-7.

PMID:
2735947
18.
19.

Long-term blockade of the dopamine uptake complex by metaphit, an isothiocyanate derivative of phencyclidine.

Zimányi I, Jacobson AE, Rice KC, Lajtha A, Reith ME.

Synapse. 1989;3(3):239-45.

PMID:
2718099
20.

Evidence that there is no direct correlation between alpha 2-adrenoceptor antagonism and inhibition of voltage-dependent sodium channels.

Zimanyi I, Lajtha A, Vizi ES, Wang E, Reith ME.

Neuropharmacology. 1988 Nov;27(11):1205-8.

PMID:
2905027
21.
22.

Interaction of yohimbine with batrachotoxinin binding to mouse brain sodium channels.

Zimanyi I, Lajtha A, Vizi ES, Reith ME.

Biochem Pharmacol. 1988 Feb 15;37(4):641-5.

PMID:
2449217
23.

The mode of action of ethanol on batrachotoxinin-A benzoate binding to sodium channels in mouse brain cortex.

Zimányi I, Lajtha A, Reith ME.

Eur J Pharmacol. 1988 Jan 27;146(1):7-16.

PMID:
2450767
25.

Release of [3H]noradrenaline by alpha 1-adrenoceptor agonists.

Vizi ES, Somogyi GT, Harsing LG Jr, Zimanyi I.

Neurochem Res. 1986 Jan;11(1):71-84.

PMID:
2870440
26.

External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation.

Vizi ES, Somogyi GT, Harsing LG, Zimanyi I.

Proc Natl Acad Sci U S A. 1985 Dec;82(24):8775-9.

27.
28.

[Correlation between psychological state and EEG finding: some aspects of behavior anomalies].

Zimányi I, Abaffy M, Sigmund A.

Acta Paediatr Acad Sci Hung. 1972;13(2):169-76. German. No abstract available.

PMID:
4671524
29.

[Changes in plasma free fatty acids after glucose loading in obese and non-obese children].

Zimányi I, Tibor L.

Acta Paediatr Acad Sci Hung. 1970;11(3):313-7. German. No abstract available.

PMID:
5525404
30.

[Splenoma in childhood; data on splenic function].

Zimányi I, Körmendy I, Gorácz G, Backhausz R, Hevér O.

Orv Hetil. 1969 Aug 31;110(35):2041-5. Hungarian. No abstract available.

PMID:
5349456
31.

[Clinical and laboratory observations with ribonucleic acid. Preliminary report].

ZIMANYI I, KOZAK E.

Orv Hetil. 1962 Sep 30;103:1844-5. Hungarian. No abstract available.

PMID:
14003666
32.

Peculiar central adiposity following poliomyelitis.

ZIMANYI I, PETER V, KARACSONYI E, SARFY E.

Confin Neurol. 1960;20:322-34. No abstract available.

PMID:
13788503
33.

Arterial hypertension after poliomyelitis.

ZIMANYI I, PROHASZKA M, SZONDY M, ORMAI S.

Acta Med Scand. 1959 Aug 31;164:497-505. No abstract available.

PMID:
13847506
34.

[Arterial hypertension after poliomyelitis].

ZIMANYI I, PROHASZKA M, SZONDY M, ORMAI S.

Orv Hetil. 1959 Apr 19;100(16):573-7. Hungarian. No abstract available.

PMID:
13645051
35.

[Thermoregulatory disturbances after poliomyelitis].

ZIMANYI I, HORVATH A.

Orv Hetil. 1958 Nov 30;99(48):1671-4. English, Hungarian. No abstract available.

PMID:
13623200
36.

[Infantile hypoglobulinemic syndrome].

ZIMANYI I, BARANYAI P.

Gyermekgyogyaszat. 1957 May-Jun;8(5-6):150-8. Hungarian. No abstract available.

PMID:
13501631
37.

[Hypoglobulinemic syndrome in childhood].

BARANYAI P, ZIMANYI I.

Ann Paediatr. 1957 Jan;188(1):16-29. German. No abstract available.

PMID:
13395121
38.

[Recovery following isonicid therapy of Darier-Roussy sarcoid].

FARKAS L, ZIMANYI I.

Orv Hetil. 1955 Jun 26;96(26):721-3. Hungarian. No abstract available.

PMID:
13254171
39.

Newly recognised correlations between disturbed kidney function and endocrine disorders.

ZIMANYI I, MALAN M, et al.

Paediatr Danub. 1948 Aug;4(2):65-85. No abstract available.

PMID:
18883988

Supplemental Content

Loading ...
Support Center